These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37217853)

  • 21. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.
    Jeong S; Oh YH; Choi S; Chang J; Kim SM; Son JS; Lee G; Ahn JC; Lee DH; Koo BK; Kim W; Park SM
    Clin Mol Hepatol; 2022 Jul; 28(3):510-521. PubMed ID: 35299291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease.
    Choi Y; Lee JE; Chang Y; Kim MK; Sung E; Shin H; Ryu S
    Br J Nutr; 2016 Oct; 116(8):1447-1456. PubMed ID: 27725000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults.
    Farhadnejad H; Tehrani AN; Jahromi MK; Teymoori F; Mokhtari E; Salehi-Sahlabadi A; Mirmiran P
    BMC Gastroenterol; 2022 May; 22(1):267. PubMed ID: 35644622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.
    Yadav D; Choi E; Ahn SV; Koh SB; Sung KC; Kim JY; Huh JH
    Medicine (Baltimore); 2016 Aug; 95(31):e4447. PubMed ID: 27495073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study.
    van den Berg EH; Wolters AAB; Dullaart RPF; Moshage H; Zurakowski D; de Meijer VE; Blokzijl H
    Liver Int; 2019 Jul; 39(7):1343-1354. PubMed ID: 30968536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.
    Kunutsor SK; Frysz M; Verweij N; Kieneker LM; Bakker SJL; Dullaart RPF
    Eur J Epidemiol; 2020 Feb; 35(2):123-137. PubMed ID: 31773475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
    Giorda C; Forlani G; Manti R; Mazzella N; De Cosmo S; Rossi MC; Nicolucci A; Russo G; Di Bartolo P; Ceriello A; Guida P;
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease.
    Mäkelä TNK; Tuomainen TP; Hantunen S; Virtanen JK
    Am J Clin Nutr; 2022 Sep; 116(3):759-770. PubMed ID: 35648467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States.
    Weintraub JA; Lopez Mitnik G; Dye BA
    J Dent Res; 2019 Oct; 98(11):1219-1226. PubMed ID: 31369716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.
    Aller R; Izaola O; Gómez S; Tafur C; González G; Berroa E; Mora N; González JM; de Luis DA
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3118-24. PubMed ID: 26367736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study.
    Zarean E; Looha MA; Amini P; Ahmadi A; Dugué PA
    BMC Public Health; 2023 Feb; 23(1):312. PubMed ID: 36774488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
    van den Berg EH; van Tienhoven-Wind LJ; Amini M; Schreuder TC; Faber KN; Blokzijl H; Dullaart RP
    Metabolism; 2017 Feb; 67():62-71. PubMed ID: 28081779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effects of lifestyle risk factors on fatty liver index.
    Nivukoski U; Niemelä M; Bloigu A; Bloigu R; Aalto M; Laatikainen T; Niemelä O
    BMC Gastroenterol; 2020 Apr; 20(1):109. PubMed ID: 32293287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary advanced glycation end products are associated with an increased risk of non-alcoholic fatty liver disease in Iranian adults.
    Jahromi MK; Tehrani AN; Teymoori F; Daftari G; Ahmadirad H; Saber N; Salehi-Sahlabadi A; Farhadnejad H; Mirmiran P
    BMC Endocr Disord; 2023 May; 23(1):111. PubMed ID: 37202817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians.
    Tayyem RF; Al-Dayyat HM; Rayyan YM
    Arab J Gastroenterol; 2019 Mar; 20(1):44-49. PubMed ID: 30872135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.